WuXi Biologics Recognized as 2025 ESG Top-Rated Company by Morningstar Sustainalytics
WuXi Biologics ,a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has been recognized as a 2025 Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics, marking the fifth consecutive year the company has scored among the highest in ESG Risk Ratings…
